The norovirus is a virus that causes gastroenteritis. Gastroenteritis is the inflammation of the gastrointestinal tract, which includes the stomach and the small intestine. Symptoms of gastroenteritis include stomach pain, diarrhea, and vomiting. Norovirus spreads very quickly and easily, including by touching objects that have the norovirus present.
According to the United States Centers for Disease Control and Prevention (CDC), the number of outbreaks of gastroenteritis on cruise ships has increased since 2001, because of increased presence of the norovirus. The CDC even has implemented a Vessel Sanitation Program (VSP) to help cruise ships curtail outbreaks of gastroenteritis. Despite this effort, twelve cruise ships reported an outbreak of gastroenteritis caused by the norovirus in 2015. Eleven cruise ships similarly reported in 2016.
After some outbreaks, the cruise ship may undertake extensive cleaning and disinfecting. The cruise ship owners bear the cost of the cleaning and disinfecting as well as the down time.
According to an aspect of the present invention, a method of limiting the spread of norovirus within a cruise ship comprises: identifying a surface within a common area of a cruise ship that passengers are likely to touch; and applying a silane quaternary ammonium ion or salt thereof to the surface.
Embodiments of the first aspect of the invention can include any one or a combination of the following features:
These and other features, advantages, and objects of the present invention will be further understood and appreciated by those skilled in the art by reference to the following specification, claims, and appended drawings.
In the drawings:
Referring now to
The cruise ship 10 further includes one or more common areas 20, which are areas that the passengers 14 are allowed to access, on the one or more decks 18. The common areas 20 include, without limitation, an elevator lobby 20a (see
Referring now to
The method further includes, at step 28, applying a silane quaternary ammonium ion or salt thereof to the surfaces 24. Preferred silane quaternary ammonium ions or salts thereof include 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium ion, 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium chloride, 3-(trihydroxysilyl)propyldimethyloctadecyl ammonium ion, or 3-(trihydroxysilyl)propyldimethyloctadecyl ammonium chloride.
Applying the silane quaternary ammonium ion or salt thereof to the surface can be made by applying, to the surface 24, a solution including the silane quaternary ammonium ion or salt thereof and a solvent. The solvent can be isopropyl alcohol, among others. The silane quaternary ammonium ion or salt thereof can comprise between 0.1 percent and 10 percent by weight of the solution. More preferably, the silane quaternary ammonium ion or salt thereof can comprise between 0.75 percent and 5 percent by weight of the solution. Even more preferably, the silane quaternary ammonium ion or salt thereof can comprise between 1.9 percent and 2.1 percent by weight of the solution. As for the isopropyl alcohol, the isopropyl alcohol can comprise between 30 percent to 90 percent by weight of the solution. More preferably, the isopropyl alcohol can comprise between 55 percent and 65 percent by weight of the solution. An example preferable solution comprises (by weight) 60.0 percent isopropyl alcohol, 2.02 percent 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium chloride, and 34.19 percent deionized water.
The solution can be applied via spraying the solution containing the silane quaternary ammonium ion or salt thereof and the solvent with an electrostatic sprayer. Alternatively, the solution can be applied with a wipe soaked with the solvent, a spray bottle containing the solvent, and other means.
Quaternary ammonium compounds are generally thought to be ineffective in destroying non-enveloped viruses. The norovirus is a non-enveloped virus. Surprisingly, testing performed pursuant to ASTM E1053 has shown that a solution including 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium chloride as the active ingredient was an effective virucidal solution against a norovirus-like virus. Because of difficulties in propagating norovirus, surrogate viruses which are able to be propagated in cell cultures have been discovered and used for testing purposes. The virus selected for the test was Bacteriophage MS2, which is a virus that infects Escherichia coli, and is an accepted surrogate virus for norovirus. Like norovirus, Bacteriophage MS2 is a non-enveloped virus.
For the testing, Petri dish carriers (a sufficient number for both test and control) were presented. The test Petri dish carriers were then sprayed five times with the solution including 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium chloride as the active ingredient. The test Petri dish carriers were sprayed at a distance of between eight and ten inches and at an angle of 45 degrees. The solution was shaken before being sprayed. The test Petri dish carriers with the solution applied thereon were then allowed to dry for fifty-eight minutes. The control Petri dish carriers were not sprayed with the solution including 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium chloride as the active ingredient.
Both the test and control Petri dish carriers were then inoculated with the Bacteriophage MS2 virus. Specifically, the carriers were inoculated with 0.2 ml of the virus, which was spread on the entire surface area on the carrier (10-in2). At time zero, the PFU/Carrier for the control carrier was measured at 9.25E+06. The carriers were then held for twenty-four hours.
Both the test and control carriers were neutralized and the level of the Bacteriophage MS2 virus remaining in each was determined. After the 24 hours holding time, the PFU/Carrier for the control carrier was 1.43E+06, and the PFU/Carrier for the test carrier was 2.95E+04. Thus, the log10 reduction compared to time zero was 0.81 for the control and 2.50 for the test (the carrier sprayed with the solution containing 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium chloride as the active ingredient). The percent reduction compared to time zero was 84.6 percent for the control and 99.7 percent for the test. The log10 reduction for the test compared to the control was 1.68. The percent reduction for the test compared to the control was 97.9 percent. This testing surprisingly demonstrated that the solution containing 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium chloride as the active ingredient satisfied the criteria for passing ASTM E1053, because a greater than 3-log10 reduction was observed in the test carrier compared to the control carrier.
The method can optionally further include, at step 30, identifying the presence of the norovirus within the cruise ship 10. Applying a silane quaternary ammonium ion or salt thereof to the surface 24 set forth above, to limit the spread of the norovirus within a cruise ship 10, can be performed either before the presence of the norovirus has been identified (as a preventative measure) or after the presence of norovirus has been identified (as a consequential measure to limit the spread of the norovirus and to reduce the amount of norovirus within the cruise ship to acceptable levels). The presence of the norovirus can be identified, for example, after an outbreak of sickness on the cruise ship 10. Documenting the existence of gastroenteritis among numerous passengers 14 of the cruise ship 10 can give rise to the assumed identification of the norovirus within the cruise ship 10.
The method can optionally further include, at step 32, wiping the surface 24 with a microfiber cloth. If the solution including the silane quaternary ammonium ion or salt thereof has been applied to the surface 24 via spraying, then beads of the solution may develop on the surface 24. Wiping the surface 24 with a microfiber cloth spreads the solution and therefore the silane quaternary ammonium ion or salt thereof over the surface 24 more uniformly.
The method can optionally further include, at step 34, testing the surface 24 for the presence of the norovirus. After the solution including the silane quaternary ammonium ion or salt thereof has been applied to the surface 24, and after waiting a preset time (such as 24 hours), the surface 24 can be tested for the presence of the norovirus. Such testing can confirm that the silane quaternary ammonium ion or salt thereof applied to the surface 24 has effectively eliminated the norovirus from the surface 24. Alternatively, such testing can confirm whether another application of the silane quaternary ammonium ion or salt thereof to the surface 24 may be required to effectively eliminate the norovirus from the surface 24.
This application is a continuation of and claims priority to U.S. patent application Ser. No. 15/807,157, filed on Nov. 8, 2017, entitled “METHOD OF LIMITING THE SPREAD OF NOROVIRUS WITHIN A CRUISE SHIP,” now U.S. Pat. No. 10,967,082, the entire disclosure of which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3241152 | Hay | Mar 1966 | A |
3515131 | Stevens | Jun 1970 | A |
3654165 | Bryant et al. | Apr 1972 | A |
4017662 | Gehman et al. | Apr 1977 | A |
4266669 | Watson | May 1981 | A |
4282366 | Eudy | Aug 1981 | A |
4372303 | Grossmann et al. | Feb 1983 | A |
4394378 | Klein | Jul 1983 | A |
4414268 | Baldwin | Nov 1983 | A |
4504541 | Yasuda et al. | Mar 1985 | A |
4603152 | Laurin et al. | Jul 1986 | A |
4735198 | Sawa | Apr 1988 | A |
4797420 | Bryant | Jan 1989 | A |
4865844 | Blank et al. | Sep 1989 | A |
4891846 | Sager et al. | Jan 1990 | A |
4921691 | Stockel | May 1990 | A |
5003970 | Parker et al. | Apr 1991 | A |
5079004 | Blank et al. | Jan 1992 | A |
5183664 | Ansell | Feb 1993 | A |
5193549 | Bellin et al. | Mar 1993 | A |
5270358 | Asmus | Dec 1993 | A |
5277698 | Taylor | Jan 1994 | A |
5411585 | Avery et al. | May 1995 | A |
5428078 | Cohen et al. | Jun 1995 | A |
5466898 | Gilbert et al. | Nov 1995 | A |
5520664 | Bricault, Jr. et al. | May 1996 | A |
5592946 | Eddy | Jan 1997 | A |
5620001 | Byrd et al. | Apr 1997 | A |
5660182 | Kuroshaki et al. | Aug 1997 | A |
5685866 | Lopez | Nov 1997 | A |
5762623 | Murphy et al. | Jun 1998 | A |
5954869 | Elfersy et al. | Sep 1999 | A |
5959014 | Liebeskind et al. | Sep 1999 | A |
6186957 | Milam | Feb 2001 | B1 |
6221944 | Liebeskind et al. | Apr 2001 | B1 |
6224579 | Modak et al. | May 2001 | B1 |
6344025 | Inagaki et al. | Feb 2002 | B1 |
6420455 | Landgrebe et al. | Jul 2002 | B1 |
6492012 | Shah | Dec 2002 | B1 |
6495229 | Carte et al. | Dec 2002 | B1 |
6520281 | Deslauriers et al. | Feb 2003 | B1 |
6575917 | Giroux et al. | Jun 2003 | B2 |
6738986 | Martin | May 2004 | B1 |
6803034 | DuVal et al. | Oct 2004 | B2 |
6821936 | Green et al. | Nov 2004 | B2 |
6821943 | Avery et al. | Nov 2004 | B2 |
6822030 | Olson et al. | Nov 2004 | B2 |
6994890 | Ohlhausen et al. | Feb 2006 | B2 |
7045673 | Batich et al. | May 2006 | B1 |
7081101 | Sawa | Jul 2006 | B1 |
7201914 | Dees | Apr 2007 | B2 |
7645824 | Hendriks et al. | Jan 2010 | B2 |
7674473 | Falder et al. | Mar 2010 | B2 |
7704313 | Ohlhausen et al. | Apr 2010 | B2 |
7709694 | Batich et al. | May 2010 | B2 |
7731564 | Sanders | Jun 2010 | B2 |
7754004 | Ohlhausen et al. | Jul 2010 | B2 |
7754625 | Hendriks et al. | Jul 2010 | B2 |
7790217 | Toreki et al. | Sep 2010 | B2 |
8025120 | Eddy | Sep 2011 | B2 |
8178484 | Schwarz et al. | May 2012 | B2 |
8257780 | Ohlhausen et al. | Sep 2012 | B2 |
8440217 | El-Naggar et al. | May 2013 | B1 |
8449483 | Eddy | May 2013 | B2 |
8491922 | Eddy | Jul 2013 | B2 |
8574844 | Burkhardt, III et al. | Nov 2013 | B2 |
8639527 | Rensvold et al. | Jan 2014 | B2 |
8679526 | Van Den Plas et al. | Mar 2014 | B2 |
8916742 | Smith | Dec 2014 | B2 |
8956665 | Bolkan et al. | Feb 2015 | B2 |
8999363 | Elfersy | Apr 2015 | B2 |
9028846 | Eddy | May 2015 | B2 |
9089138 | Higgins et al. | Jul 2015 | B2 |
9095731 | Gentle et al. | Aug 2015 | B2 |
9149393 | Cumming et al. | Oct 2015 | B2 |
9204677 | Abbey et al. | Dec 2015 | B2 |
9215903 | Abbey et al. | Dec 2015 | B2 |
9254591 | Fox et al. | Feb 2016 | B2 |
9375346 | Sundheimer et al. | Jun 2016 | B1 |
9433708 | Eddy | Sep 2016 | B2 |
9675735 | Eddy | Jun 2017 | B2 |
9717249 | Eddy | Aug 2017 | B2 |
9757769 | Grossman et al. | Sep 2017 | B2 |
9795141 | Chason et al. | Oct 2017 | B2 |
9795177 | Weaver | Oct 2017 | B1 |
9834874 | Stein | Dec 2017 | B2 |
9840626 | Farrugia et al. | Dec 2017 | B2 |
9845569 | Dunn et al. | Dec 2017 | B2 |
9855584 | Grossman et al. | Jan 2018 | B2 |
9877875 | Eddy | Jan 2018 | B2 |
9877879 | Beck | Jan 2018 | B2 |
9943135 | Baychar | Apr 2018 | B2 |
10039683 | Jung et al. | Aug 2018 | B2 |
10045536 | Chason et al. | Aug 2018 | B2 |
10212932 | Chiattello et al. | Feb 2019 | B2 |
10258046 | Grossman et al. | Apr 2019 | B2 |
10258411 | Ferguson | Apr 2019 | B1 |
10306884 | Howard, Jr. | Jun 2019 | B1 |
10388143 | Eddy et al. | Aug 2019 | B2 |
10470689 | Kilcran et al. | Nov 2019 | B2 |
10472157 | Dudding et al. | Nov 2019 | B1 |
10758426 | Eddy | Sep 2020 | B2 |
10822502 | Eddy | Nov 2020 | B2 |
10864058 | Eddy | Dec 2020 | B2 |
10967082 | Eddy | Apr 2021 | B2 |
20020111282 | Charaf et al. | Aug 2002 | A1 |
20020170771 | Milam et al. | Nov 2002 | A1 |
20030073600 | Avery et al. | Apr 2003 | A1 |
20040019286 | Lia et al. | Jan 2004 | A1 |
20040151919 | Bagwell et al. | Aug 2004 | A1 |
20040166173 | Albach | Aug 2004 | A1 |
20050008763 | Schachter | Jan 2005 | A1 |
20050035164 | Badillo | Feb 2005 | A1 |
20050187580 | Skiba | Aug 2005 | A1 |
20050227895 | Ghosh et al. | Oct 2005 | A1 |
20060127498 | Sugiura | Jun 2006 | A1 |
20060223962 | Getman et al. | Oct 2006 | A1 |
20060293623 | Carroll | Dec 2006 | A1 |
20070021383 | Loder | Jan 2007 | A1 |
20070038132 | Kishimoto et al. | Feb 2007 | A1 |
20070038243 | Rutherford | Feb 2007 | A1 |
20070042198 | Schonemyr et al. | Feb 2007 | A1 |
20070065475 | Elfersy | Mar 2007 | A1 |
20070088224 | Friedman et al. | Apr 2007 | A1 |
20070129636 | Friedman et al. | Jun 2007 | A1 |
20070166344 | Qu et al. | Jul 2007 | A1 |
20070193822 | Statner et al. | Aug 2007 | A1 |
20070218096 | Wooley | Sep 2007 | A1 |
20070227930 | Bromberg et al. | Oct 2007 | A1 |
20070275929 | Fuls et al. | Nov 2007 | A1 |
20080033329 | Downs et al. | Feb 2008 | A1 |
20080166384 | Jones | Jul 2008 | A1 |
20080171068 | Wyner et al. | Jul 2008 | A1 |
20080193497 | Samuelsen et al. | Aug 2008 | A1 |
20080236596 | Pierskalla et al. | Oct 2008 | A1 |
20080242794 | Sandford et al. | Oct 2008 | A1 |
20080260804 | Morris et al. | Oct 2008 | A1 |
20080264445 | Levitt et al. | Oct 2008 | A1 |
20090074881 | Kielbania, Jr. | Mar 2009 | A1 |
20090196896 | Patton et al. | Aug 2009 | A1 |
20090215917 | Trotter et al. | Aug 2009 | A1 |
20090223411 | Higgins et al. | Sep 2009 | A1 |
20090227454 | Jaiswal | Sep 2009 | A1 |
20090252647 | Orofino | Oct 2009 | A1 |
20090259157 | Thomas | Oct 2009 | A1 |
20090281368 | Krubsack et al. | Nov 2009 | A1 |
20090285890 | Van Den Plas et al. | Nov 2009 | A1 |
20090288908 | Giroux et al. | Nov 2009 | A1 |
20090291147 | Sandford et al. | Nov 2009 | A1 |
20090307843 | Hookway et al. | Dec 2009 | A1 |
20090312684 | Leonard et al. | Dec 2009 | A1 |
20100028462 | Bolkan et al. | Feb 2010 | A1 |
20100032231 | Statner et al. | Feb 2010 | A1 |
20100056485 | Park | Mar 2010 | A1 |
20100063431 | Bae | Mar 2010 | A1 |
20100086580 | Nyman et al. | Apr 2010 | A1 |
20100089408 | McCaughey et al. | Apr 2010 | A1 |
20100113871 | Dias et al. | May 2010 | A1 |
20100137764 | Eddy | Jun 2010 | A1 |
20100159256 | Yamasaki et al. | Jun 2010 | A1 |
20100167978 | Iyer et al. | Jul 2010 | A1 |
20100197748 | Schwarz et al. | Aug 2010 | A1 |
20100255178 | Leander et al. | Oct 2010 | A1 |
20100331710 | Eddy | Dec 2010 | A1 |
20110084578 | Newkirk et al. | Apr 2011 | A1 |
20110124772 | Wang et al. | May 2011 | A1 |
20110186462 | Storey et al. | Aug 2011 | A1 |
20110200655 | Black et al. | Aug 2011 | A1 |
20110209835 | Balbona et al. | Sep 2011 | A1 |
20110233810 | Neigel et al. | Sep 2011 | A1 |
20110236504 | Hata et al. | Sep 2011 | A1 |
20110245743 | Eddy | Oct 2011 | A1 |
20110250626 | Williams et al. | Oct 2011 | A1 |
20110271873 | Ohlhausen et al. | Nov 2011 | A1 |
20110282302 | Lopez et al. | Nov 2011 | A1 |
20120015200 | Ali et al. | Jan 2012 | A1 |
20120021405 | Palzkill et al. | Jan 2012 | A1 |
20120052106 | Eddy | Mar 2012 | A1 |
20120052289 | Jing et al. | Mar 2012 | A1 |
20120070481 | Bolkan et al. | Mar 2012 | A1 |
20120070509 | Sugiura | Mar 2012 | A1 |
20120134953 | Gentle et al. | May 2012 | A1 |
20120135188 | Proton | May 2012 | A1 |
20120136313 | Smith | May 2012 | A1 |
20120157567 | Ou et al. | Jun 2012 | A1 |
20120157904 | Stein | Jun 2012 | A1 |
20120173274 | Rensvold et al. | Jul 2012 | A1 |
20120246788 | Harrell et al. | Oct 2012 | A1 |
20120263910 | Baychar | Oct 2012 | A1 |
20120296252 | Cumming et al. | Nov 2012 | A1 |
20130017242 | Richardson et al. | Jan 2013 | A1 |
20130045265 | Chapman | Feb 2013 | A1 |
20130101674 | Toft | Apr 2013 | A1 |
20130101677 | Callahan et al. | Apr 2013 | A1 |
20130231599 | Eddy | Sep 2013 | A1 |
20130273132 | Eddy | Oct 2013 | A1 |
20130273133 | Eddy | Oct 2013 | A1 |
20130338553 | Eddy | Dec 2013 | A1 |
20130345170 | Eddy | Dec 2013 | A1 |
20140011766 | Krafft | Jan 2014 | A1 |
20140051732 | Ghannoum et al. | Feb 2014 | A1 |
20140066869 | Toft | Mar 2014 | A1 |
20140100504 | Eddy | Apr 2014 | A1 |
20140199356 | Chason et al. | Jul 2014 | A1 |
20140199358 | Chason et al. | Jul 2014 | A1 |
20140199359 | Chason et al. | Jul 2014 | A1 |
20140221876 | Eddy | Aug 2014 | A1 |
20140256382 | Eddy | Sep 2014 | A1 |
20140271794 | Eddy | Sep 2014 | A1 |
20140276456 | Eddy | Sep 2014 | A1 |
20140302168 | Perry | Oct 2014 | A1 |
20140326192 | Coupe et al. | Nov 2014 | A1 |
20140352039 | Abbey et al. | Dec 2014 | A1 |
20150004361 | Culpepper | Jan 2015 | A1 |
20150005684 | Evans | Jan 2015 | A1 |
20150011716 | Lombardi | Jan 2015 | A1 |
20150024019 | Ali et al. | Jan 2015 | A1 |
20150031729 | Ghannoum et al. | Jan 2015 | A1 |
20150080827 | Fogg | Mar 2015 | A1 |
20150086597 | Mallak et al. | Mar 2015 | A1 |
20150089720 | Abbey et al. | Apr 2015 | A1 |
20150143615 | LePage | May 2015 | A1 |
20150158608 | Talarico | Jun 2015 | A1 |
20150305343 | Burke et al. | Oct 2015 | A1 |
20150328240 | Hilliard et al. | Nov 2015 | A1 |
20150352320 | Eddy | Dec 2015 | A1 |
20160051389 | Seligman | Feb 2016 | A1 |
20160107411 | Fox et al. | Apr 2016 | A1 |
20160143275 | Lan et al. | May 2016 | A1 |
20160143276 | Lan et al. | May 2016 | A1 |
20160151189 | Romo et al. | Jun 2016 | A1 |
20160171179 | Donofrio et al. | Jun 2016 | A1 |
20160262382 | Lan et al. | Sep 2016 | A1 |
20160262383 | Lan et al. | Sep 2016 | A1 |
20160295858 | Mason et al. | Oct 2016 | A1 |
20160354005 | Oakley et al. | Dec 2016 | A1 |
20160361478 | Eddy | Dec 2016 | A1 |
20170000115 | Nassar et al. | Jan 2017 | A1 |
20170000651 | Cumming et al. | Jan 2017 | A1 |
20170027269 | Wilson et al. | Feb 2017 | A1 |
20170081707 | Dillon et al. | Mar 2017 | A1 |
20170106622 | Bonin | Apr 2017 | A1 |
20170176146 | Böhringer et al. | Jun 2017 | A1 |
20170224043 | Bouchard-Fortin et al. | Aug 2017 | A1 |
20170236398 | Eddy et al. | Aug 2017 | A1 |
20170246041 | Cumming et al. | Aug 2017 | A1 |
20170265475 | Chason et al. | Sep 2017 | A1 |
20170274114 | Song et al. | Sep 2017 | A1 |
20170280716 | Lan et al. | Oct 2017 | A1 |
20170319758 | Eddy et al. | Nov 2017 | A1 |
20170367899 | Lundh et al. | Dec 2017 | A1 |
20180028431 | Chiattello et al. | Feb 2018 | A1 |
20180055695 | Park | Mar 2018 | A1 |
20180080605 | Janway et al. | Mar 2018 | A1 |
20180139959 | Nassar et al. | May 2018 | A1 |
20180224674 | Carabin | Aug 2018 | A1 |
20180243790 | Grossman et al. | Aug 2018 | A1 |
20190046081 | Kilcran et al. | Feb 2019 | A1 |
20190046082 | Kilcran et al. | Feb 2019 | A1 |
20190046083 | Kilcran et al. | Feb 2019 | A1 |
20190046084 | Kilcran et al. | Feb 2019 | A1 |
20190046364 | Kilcran et al. | Feb 2019 | A1 |
20190051137 | Kilcran et al. | Feb 2019 | A1 |
20190125774 | Eddy | May 2019 | A1 |
20190134244 | Eddy | May 2019 | A1 |
20190166828 | Storey et al. | Jun 2019 | A1 |
20190209381 | Cumming et al. | Jul 2019 | A9 |
20190216090 | Alimi et al. | Jul 2019 | A1 |
20190223445 | Seo et al. | Jul 2019 | A1 |
20190254865 | Eddy | Aug 2019 | A1 |
20190255210 | Eddy | Aug 2019 | A1 |
20190276681 | Eddy | Sep 2019 | A1 |
20190289954 | Baychar | Sep 2019 | A1 |
20190298479 | Eddy | Oct 2019 | A1 |
20190360781 | Böhringer et al. | Nov 2019 | A1 |
20200022421 | Kilbey | Jan 2020 | A1 |
20200068896 | Eddy | Mar 2020 | A1 |
20200071540 | Eddy | Mar 2020 | A1 |
20200095775 | Eddy | Mar 2020 | A1 |
20200097936 | Eddy | Mar 2020 | A1 |
20200281288 | Eddy | Sep 2020 | A1 |
20200281774 | Eddy | Sep 2020 | A1 |
20200282099 | Eddy | Sep 2020 | A1 |
20210052345 | Eddy | Feb 2021 | A1 |
20210137120 | Eddy et al. | May 2021 | A1 |
20210299307 | Eddy | Sep 2021 | A1 |
20210299309 | Eddy | Sep 2021 | A1 |
Number | Date | Country |
---|---|---|
0108853 | May 1984 | EP |
0129980 | Jan 1985 | EP |
1600105 | Nov 2005 | EP |
2377400 | Oct 2011 | EP |
2200594 | Aug 1988 | GB |
1020060055894 | May 2006 | KR |
2540478 | Feb 2015 | RU |
2599004 | Oct 2016 | RU |
0054587 | Sep 2000 | WO |
0072850 | Dec 2000 | WO |
2004087226 | Oct 2004 | WO |
2005042657 | May 2005 | WO |
2007061625 | May 2007 | WO |
2007076413 | Jul 2007 | WO |
2008076839 | Jun 2008 | WO |
2008097599 | Aug 2008 | WO |
2012037615 | Mar 2012 | WO |
2013102021 | Jul 2013 | WO |
2016130837 | Aug 2016 | WO |
Entry |
---|
Murray et al., “Microbial Inhibition on Hospital Garments Treated with Dow Corning 5700 Antimicrobial Agent,” Journal of Clinical Microbiology, vol. 26, No. 9, Sep. 1988, pp. 1884-1886. |
Rutala et al., “Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008,” Centers for Disease Control (CDC), Department of Health & Human Services, Feb. 15, 2017 (161 pages). |
U.S. Food & Drug Administration (FDA), “Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling Guidance for Industry and Food and Drug Administration Staff,” Mar. 17, 2015 (44 pages). |
European Commission, “Aerosol Dispensers Directive Evaluation—Background document”, Sep. 23, 2016, Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, Belgium (1 page). |
Monticello, Robert A., “The Use of Reactive Silane Chemistries to Provide Durable, Non-Leaching Antimicrobial Surfaces”, AEGIS Environments, Midland, Michigan USA, Jan. 1, 2010 (77 pages). |
AEGIS Environments, Material Safety Data Sheet Aegis Microbe Shield(TM) Program—AEGIS(TM) Antimicrobial (Typical Application Strength), Midland, Michigan USA, May 12, 2004 (5 pages). |
Federal Institute of Industrial Property, “The International Search Report and the Written Opinion of the International Searching Authority,” dated Jan. 24, 2019 (9 pages). |
World Health Organization, “Guide to marine sanitation,” Third Edition, 2013, pp. 90 and 147-149. |
Jimenez et al: “Virucidal activity of a quaternary ammonium compound disinfectant against feline calicivirus: A surrogate for norovirus”, AJIC: American Journal of Infection Control, vol. 34, No. 5, Jun. 1, 2006 (Jun. 1, 2006), pp. 269-273, Elsevier, Amsterdam, NL. |
Anonymous: “Guidance for the Management of Norovirus Infection in Cruise Ships”, ⋅ Jul. 1, 2007 (Jul. 1, 2007), pp. 1-76, Retrieved from the Internet: URL:https://virox.com/files docs/content/pdf/msds/1206520183347.pd, [retrieved on Jan. 28, 2021]. |
Anonymous.: “Guide to ship sanitation (third edition)”, Guide to Ship Sanitation (Third Edition), World Health Organization, CH, pp. 1-171, Nov. 30, 2012 (Nov. 30, 2012), Retrieved from the Internet: URL: https://www.who.int/water sanitation health/publications/2011/ship-sanitation-guide/en/, pp. 133-135. |
Extended European Search Report, European Application No. 18875379.2, dated Feb. 11, 2021 (6 pages). |
Anonymous. 2009. SiSiB PC9911 Antimicrobial. Power Chemical Corp. [online]; downloaded from URL<http://www.powerchemcorp.com/library/public/SiSiB_PC9911.pdf> on Oct. 8, 2013; 2 pages. |
http://www.ncbi.nlm.nih.gov/pubmed/7753434, 1995 [retrieved on Dec. 4, 2012]. |
“Graft Polymerization onto Wool Pretreated with a Mercaptosilane”, Textile Research Journal, Aug. 1996, vol. 66, No. 8, 529-532. |
Sickbert-Bennett et al., “Comparative Efficacy of Hand Hygiene Agents in the Reductions of Bacteria and Viruses”, 2005, pp. 67-77, vol. 33, No. 2, Association for Professionals in Infection Control and Epidemiology, Inc. |
http://www.bovie.com/germgate-factsheet1.html [retrieved on Jun. 10, 2010]. |
http://www.andonline.com/and_med.nsf/html/UA-851THW [retrieved on Jun. 10, 2010]. |
http://www.zorotools.com/g/Respirator%20Antimicrobial%20Wipes/00118290 [retrieved on Dec. 4, 2012]. |
ICU Medical, Inc., “MicroClave Neutral Displacement Connector”, 2012, M1-1113 Rev. 10, 4 pages. |
ICU Medical, Inc., “Antimicrobial MicroClave Neutral Displacement Connector”, 2012, M1-1248 Rev. 04, 2 pages. |
Anonymous: “Guide to ship sanitation (third edition)”, 2011, pp. iii-155 (total pages 171), World Health Organization, Switzerland. |
Proguard Quaternary Disinfectant (http://www.kellysolutions.com/wa/showA 1.asp?Basic_EPA_ID=6836%2D78&EPA_ID=6836%2D78%2D1677&Product_Name=Quaternary+Disinfectant+Cleaner+ProGuard (downloaded on Jun. 26, 2013)). |
Sarah Coleman, To Bandage or Not To Bandage: Decoding Thoroughbred Leg Wrappings, Dec. 22, 2015, pp. 1-4 https://www.paulickreport.com/horse-care-category/the-great-bandage-debate-decoding-thoroughbred-leg-wrappings/ (Year: 2015). |
A-Tape Cohesive Crepe Bandage Red (Pack 2) Elastic Self Adhesive (10 cm x 4.5 mtr) hhttps://www.amazon.in/Bandages-Assorted-Colors-Waterproof-Adherent/dp/B01I62O0CM (Year: 2016). |
Measurement Canada document (https://www.ic.gc.ca/eic/site/mc-mc.nsf/vwapj/VCF-FCV_CAS-67-63-0.pdf/$file/NCF-FCV_CAS-67-63-0.pdf, accessed Apr. 15, 2016, pp. 1-2). |
Mahltig B., Grethe T., Haase H. (Jun. 1, 2018) Antimicrobial Coatings Obtained by Sol-Gel Method. In: Klein L., Aparicio M., Jitianu A. (eds) Handbook of Sol-Gel Science and Technology. Springer, Cham. (“Antimicrobial”). |
https://www.fullerindustriesllc.com/franklin-cleaning-technology/quasar/, [retrieved on Nov. 16, 2021]. |
European Patent Office, “Extended European Search Report”, European Application No. 19194187.1, dated Nov. 18, 2019 (12 pages). |
http://www.igenericdrugs.com/?s= Life%20Brand%20Disinfectant%20Wipes [retrieved on Dec. 4, 2012]. |
Number | Date | Country | |
---|---|---|---|
20210121591 A1 | Apr 2021 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15807157 | Nov 2017 | US |
Child | 17141756 | US |